Pages that link to "Q37235277"
Jump to navigation
Jump to search
The following pages link to Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag. (Q37235277):
Displaying 9 items.
- HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies (Q26799624) (← links)
- Vector-based genetically modified vaccines: Exploiting Jenner’s legacy (Q28114565) (← links)
- Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines. (Q30358493) (← links)
- Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice (Q34501283) (← links)
- Modulation of systemic and mucosal immunity against an inactivated vaccine of Newcastle disease virus by oral co-administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interleukin-18 and interferon-α. (Q35594410) (← links)
- Antigen localisation influences the magnitude and kinetics of the endogenous adaptive immune response to recombinant Salmonella vaccines. (Q40052536) (← links)
- Salmonella typhimurium and Escherichia coli dissimilarity: Closely related bacteria with distinct metabolic profiles. (Q41147322) (← links)
- Nonspecific effects of oral vaccination with live-attenuated Typhi strain Ty21a (Q62486559) (← links)
- Prolonging and enhancing the protective efficacy of the EtMIC3-C-MAR against eimeria tenella through delivered by attenuated salmonella typhimurium (Q90111841) (← links)